1. Home
  2. SCNI vs CETX Comparison

SCNI vs CETX Comparison

Compare SCNI & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • CETX
  • Stock Information
  • Founded
  • SCNI 2003
  • CETX 1998
  • Country
  • SCNI Israel
  • CETX United States
  • Employees
  • SCNI N/A
  • CETX N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • CETX EDP Services
  • Sector
  • SCNI Health Care
  • CETX Technology
  • Exchange
  • SCNI Nasdaq
  • CETX Nasdaq
  • Market Cap
  • SCNI 4.6M
  • CETX 4.3M
  • IPO Year
  • SCNI N/A
  • CETX 1998
  • Fundamental
  • Price
  • SCNI $1.37
  • CETX $5.31
  • Analyst Decision
  • SCNI
  • CETX
  • Analyst Count
  • SCNI 0
  • CETX 0
  • Target Price
  • SCNI N/A
  • CETX N/A
  • AVG Volume (30 Days)
  • SCNI 95.4K
  • CETX 162.2K
  • Earning Date
  • SCNI 11-21-2025
  • CETX 08-14-2025
  • Dividend Yield
  • SCNI N/A
  • CETX N/A
  • EPS Growth
  • SCNI N/A
  • CETX N/A
  • EPS
  • SCNI 0.26
  • CETX N/A
  • Revenue
  • SCNI $1,147,000.00
  • CETX $76,095,551.00
  • Revenue This Year
  • SCNI N/A
  • CETX $19.77
  • Revenue Next Year
  • SCNI N/A
  • CETX $15.00
  • P/E Ratio
  • SCNI $5.20
  • CETX N/A
  • Revenue Growth
  • SCNI 303.87
  • CETX 16.50
  • 52 Week Low
  • SCNI $1.20
  • CETX $4.81
  • 52 Week High
  • SCNI $6.18
  • CETX $272.84
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 45.19
  • CETX 72.31
  • Support Level
  • SCNI $1.32
  • CETX $4.95
  • Resistance Level
  • SCNI $1.63
  • CETX $5.67
  • Average True Range (ATR)
  • SCNI 0.11
  • CETX 0.48
  • MACD
  • SCNI 0.01
  • CETX 0.18
  • Stochastic Oscillator
  • SCNI 38.37
  • CETX 85.60

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: